跳至主要内容
临床试验/NCT00877669
NCT00877669已完成2 期

The Comparison of Efficacy Between Holmium Laser Enucleation of the Prostate (HoLEP) and Transurethral Resection of the Prostate (TURP) on the Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostate Hyperplasia (BPH)

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 313 人开始时间: 2008年10月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
313
试验地点
1
主要终点
The changes of International Prostatic Symptom Scores (IPSS) from baseline to 6 months after operation

研究概览

简要总结

The purpose of this study is to compare of Efficacy and Safety Between Holmium Laser Enucleation of the Prostate (HoLEP) and Transurethral Resection of the Prostate (TURP) on the Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostate Hyperplasia (BPH).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •50 yrs or greater
  • •International prostatic symptom score >= 12
  • •Bladder outlet obstruction confirmed by pressure-flow study (BOOI > 20)
  • •Able to give fully informed consent

排除标准

  • •Patients with urologic malignancies such as prostate cancer and bladder cancer
  • •Patients underwent urethral, prostate surgery
  • •Patients with urethral stricture or bladder diverticulum or bladder neck contracture
  • •Patients with histories of bacterial prostatitis within 1 year
  • •seems not to be appropriate to this study by the decision of investigators because of any other reasons

研究组 & 干预措施

Transurethral resection of the prostate

Active Comparator

TURP group

干预措施: Transurethral resection of the prostate (Procedure)

Holmium Laser Enucleation of Prostate

Experimental

HoLEP group

干预措施: Holmium Laser Enucleation of the Prostate (Procedure)

结局指标

主要结局

The changes of International Prostatic Symptom Scores (IPSS) from baseline to 6 months after operation

时间窗: 6 months

次要结局

  • The changes of IPSS and QoL parameters(1 month and 3months after operation)
  • Operative time and Resected tissue weight(0 day after operation)
  • The changes of Patient perception of treatment benefit questionnaire (PPTB) parameters(3 and 6 months after operation)
  • Ejaculation parameter(6 months after operation)
  • The changes of the hemoglobin and the serum sodium(0 and 1 day after operation)
  • The changes of Quality of Life (QoL) parameters(6 months)
  • The changes of Uroflowmetry (UFM) and Postvoid residual urine(PVR) parameters(2 weeks and 3 and 6 months after operation)
  • The changes of voiding frequencies and urgency parameters in Frequency volume chart(3 and 6 months after operation)
  • The changes of ICS male questionnaire (short form) parameters(3 and 6 months after operation)
  • The changes of international index of erectile function (IIEF)-15 parameters(6 months after operation)
  • Postoperative hospital stay days and postoperative catheterization days(immediate postoperative period)
  • Complications(During all study periods)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

KYU-SUNG LEE

Urology, Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验